These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 15772908)

  • 21. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4.
    Unal-Cevik I; Sarioglu-Ay S; Evcik D
    J Pain; 2010 Nov; 11(11):1129-35. PubMed ID: 20418179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cognitive risk profile for pain: development of a self-report inventory for identifying beliefs and attitudes that interfere with pain management.
    Cook AJ; Degood DE
    Clin J Pain; 2006 May; 22(4):332-45. PubMed ID: 16691085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
    Hamdan A; Luna JD; Del Pozo E; Gálvez R
    Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
    Cho SI; Lee CH; Park GH; Park CW; Kim HO
    J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
    Hans G; Joukes E; Verhulst J; Vercauteren M
    Curr Med Res Opin; 2009 Nov; 25(11):2737-43. PubMed ID: 19788351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting.
    Isomura T; Sumitani M; Matsudaira K; Kawaguchi M; Inoue R; Hozumi J; Tanaka T; Oshima H; Mori K; Taketomi S; Inui H; Tahara K; Yamagami R; Hayakawa K
    Pain Pract; 2017 Jul; 17(6):800-807. PubMed ID: 27770598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.
    Bennett M
    Pain; 2001 May; 92(1-2):147-57. PubMed ID: 11323136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
    Garoushi S; Johnson MI; Tashani OA
    Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between pain and neuropathic symptoms in chronic musculoskeletal pain.
    Giske L; Bautz-Holter E; Sandvik L; Røe C
    Pain Med; 2009; 10(5):910-7. PubMed ID: 19453955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the LANSS scale be used to classify pain in chronic cancer pain trials?
    Hardy J; Quinn S; Fazekas B; Agar M; Currow D
    Support Care Cancer; 2013 Dec; 21(12):3387-91. PubMed ID: 23934225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2).
    Dworkin RH; Turk DC; Revicki DA; Harding G; Coyne KS; Peirce-Sandner S; Bhagwat D; Everton D; Burke LB; Cowan P; Farrar JT; Hertz S; Max MB; Rappaport BA; Melzack R
    Pain; 2009 Jul; 144(1-2):35-42. PubMed ID: 19356853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Vasc Nurs; 2005 Sep; 23(3):97-104. PubMed ID: 16125633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.
    Hans G; Masquelier E; De Cock P
    BMC Public Health; 2007 Jul; 7():170. PubMed ID: 17650299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
    Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
    J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
    Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
    Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
    Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
    Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis.
    Rog DJ; Nurmikko TJ; Friede T; Young CA
    Clin J Pain; 2007; 23(6):473-81. PubMed ID: 17575486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.